DermTech, Inc. (DMTK): Price and Financial Metrics
DermTech, Inc. (DMTK)
Today's Latest Price: $45.48 USD
Updated Jan 25 4:00pm
Add DMTK to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 64 in Medical - Diagnostics/Research
See all "A" rated Strong Buy stocks
DMTK Stock Summary
- The ratio of debt to operating expenses for DermTech Inc is higher than it is for about merely 0.53% of US stocks.
- DMTK's price/sales ratio is 157.14; that's higher than the P/S ratio of 97.17% of US stocks.
- In terms of volatility of its share price, DMTK is more volatile than 93.8% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to DermTech Inc are REFR, IGC, ECOR, APYX, and CUTR.
- Visit DMTK's SEC page to see the company's official filings. To visit the company's web site, go to www.dermtech.com.
DMTK Stock Price Chart Interactive Chart >
DMTK Price/Volume Stats
| Current price | $45.48 | 52-week high | $47.08 |
| Prev. close | $42.92 | 52-week low | $8.69 |
| Day low | $42.02 | Volume | 1,470,900 |
| Day high | $47.08 | Avg. volume | 1,352,040 |
| 50-day MA | $22.51 | Dividend yield | N/A |
| 200-day MA | $14.89 | Market Cap | 891.18M |
DermTech, Inc. (DMTK) Company Bio
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Loading social stream, please wait...